Aurinia: Q1 Earnings Snapshot
Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $26.2 million in its first quarter. The Victoria, British Columbia-based company said it had a loss of 18 cents per share. The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share
VICTORIA, British Columbia (AP) — VICTORIA, British Columbia (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $26.2 million in its first quarter.
The Victoria, British Columbia-based company said it had a loss of 18 cents per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.
The biotechnology company posted revenue of $34.4 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $27.7 million.
Aurinia shares have more than doubled since the beginning of the year. The stock has climbed 5% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a AUPH">Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH
